# Ketorolac in Upper Extremity Tendinopathy and Arthropathy

> **NCT05292339** · PHASE4 · RECRUITING · sponsor: **Emory University** · enrollment: 160 (estimated)

## Conditions studied

- Osteoarthritis
- Tendinopathy
- Arthropathy

## Interventions

- **DRUG:** Triamcinolone injection to the shoulder, elbow, wrist, or hand
- **DRUG:** Ketorolac injection to the shoulder, elbow, wrist, or hand

## Key facts

- **NCT ID:** NCT05292339
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-31
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292339, "Ketorolac in Upper Extremity Tendinopathy and Arthropathy". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT05292339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*